… based vaccine design … therapeutic agents and vaccines for COVID-19 35 . In this review,
we aim to discuss the current status of diagnostics, therapeutics, and vaccines against COVID-19…

… Additionally, we reviewed the novel pharmacological intervention approaches and
vaccine development strategies against COVID-19. We speculate that the current pandemic …

… The gateway of advancement for peptide-based therapeutics … for tackling COVID-19 viral
infection, such as peptide vaccines, … Currently, there is no precise treatment for COVID-19. Thus, …

… -2 vaccines and therapies has been sparked by the COVID-19 pandemic. Two years ago,
COVID-19’… In this review, we explore the potential of mRNA as a vaccine and therapeutic using …

… the toxicities of potential therapeutics for COVID-19 and possible treatments for … Therapeutics
Researchers are currently investigating treatments for COVID-19, by developing vaccines …

… MW is currently employed by Moderna Inc., which is pursuing therapeutic and vaccine
development to treat COVID-19. AA is a consultant for Vir Biotechnology. The other authors …

… as well as various types of vaccines. More than 500 patents … coronavirus infections, which
may be applicable to COVID-19. … ongoing development of therapeutic agents and vaccines. …

… for COVID-19 vaccines and therapeutics is essential to resilience and sustainability in our
world. For vaccines, … including CEPI have warned that COVID-19 vaccines will not be available …

… vaccines the global numbers of new infections as well as patients developing severe COVID-19,
… Until today, emergency use-approved treatment options for COVID-19 are limited to the …

… risk for impaired vaccine responses, … vaccination and infection are frequently impaired
leaving them more vulnerable to prolonged high viral loads and severe complications of COVID-19…